- Home
- ACIU vs ZURA Comparison
ACIU vs ZURA Comparison
Compare ACIU & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- ZURA
- Stock Information
- Founded
- ACIU 2003
- ZURA 2022
- Country
- ACIU Switzerland
- ZURA United States
- Employees
- ACIU N/A
- ZURA N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ACIU Health Care
- ZURA Health Care
- Exchange
- ACIU Nasdaq
- ZURA Nasdaq
- Market Cap
- ACIU 332.4M
- ZURA 292.1M
- IPO Year
- ACIU 2016
- ZURA N/A
- Fundamental
- Price
- ACIU $3.16
- ZURA $2.83
- Analyst Decision
- ACIU Strong Buy
- ZURA Buy
- Analyst Count
- ACIU 2
- ZURA 6
- Target Price
- ACIU $12.00
- ZURA $15.80
- AVG Volume (30 Days)
- ACIU 137.8K
- ZURA 361.1K
- Earning Date
- ACIU 11-05-2024
- ZURA 11-07-2024
- Dividend Yield
- ACIU N/A
- ZURA N/A
- EPS Growth
- ACIU N/A
- ZURA N/A
- EPS
- ACIU N/A
- ZURA N/A
- Revenue
- ACIU $48,505,404.00
- ZURA N/A
- Revenue This Year
- ACIU $85.33
- ZURA N/A
- Revenue Next Year
- ACIU $80.69
- ZURA N/A
- P/E Ratio
- ACIU N/A
- ZURA N/A
- Revenue Growth
- ACIU 4097200.00
- ZURA N/A
- 52 Week Low
- ACIU $2.25
- ZURA $2.00
- 52 Week High
- ACIU $5.14
- ZURA $6.35
- Technical
- Relative Strength Index (RSI)
- ACIU 45.92
- ZURA 32.13
- Support Level
- ACIU $3.16
- ZURA $2.71
- Resistance Level
- ACIU $3.48
- ZURA $3.10
- Average True Range (ATR)
- ACIU 0.20
- ZURA 0.31
- MACD
- ACIU -0.01
- ZURA -0.05
- Stochastic Oscillator
- ACIU 6.41
- ZURA 5.71
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About ZURA Zura Bio Limited
Zura Bio Ltd is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders.